Analysis of SiO2 nanoparticles binding proteins in rat blood and brain homogenate

International Journal of Nanomedicine

Volumn 9, Issue , 2014, Pages 207-215

  Shim, Kyu Hwan ^a   Hulme, John ^a   Maeng, Eun Ho ^b   Kim, Meyoung Kon ^c   An, Seong Soo A ^a  

^a Gachon University   (South Korea)

^b KTF   (South Korea)

^c Korea University   (South Korea)

Author keywords

Brain homogenate; Nanoparticles; Nanotoxicity; Plasma; Protein corona; Silica

Indexed keywords

ARGININE; BINDING PROTEIN; NANOCOATING; PLASMA PROTEIN; SILICA NANOPARTICLE; NANOPARTICLE; PROTEIN BINDING; SILICON DIOXIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CELL; BRAIN HOMOGENATE; COMPUTER PROGRAM; CONTROLLED STUDY; GENE ONTOLOGY; LIQUID CHROMATOGRAPHY; MOLECULAR BIOLOGY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; SURFACE CHARGE; TANDEM MASS SPECTROMETRY; ANIMAL; BRAIN; BRAIN CHEMISTRY; CHEMISTRY; METABOLISM;

ANIMALS; BLOOD PROTEINS; BRAIN; BRAIN CHEMISTRY; NANOPARTICLES; PROTEIN BINDING; RATS; SILICON DIOXIDE;

EID: 84924875001     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S58203     Document Type: Article

References (46)

1. Liu D, He X, Wang K, He C, Shi H, Jian L. Biocompatible silica nanoparticles-insulin conjugates for mesenchymal stem cell adipogenic differentiation. Bioconjug Chem. 2010;21(9):1673–1684
2. Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater. 2009;8(4):331–336
3. Tarn D, Ashley CE, Xue M, Carnes EC, Zink JI, Brinker CJ. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Acc Chem Res. 2013;46(3):792–801
4. Barandeh F, Nguyen PL, Kumar R, et al. Organically modified silica nanoparticles are biocompatible and can be targeted to neurons in vivo. PLoS One. 2012;7(1):e29424
5. Dragic P, Kucera C, Furtick J, Guerrier J, Hawkins T, Ballato J. Brillouin spectroscopy of a novel baria-doped silica glass optical fiber. Opt Express. 2013;21(9):10924–10941
6. Watanabe W, Kuroda D, Itoh K, Nishii J. Fabrication of Fresnel zone plate embedded in silica glass by femtosecond laser pulses. Opt Express. 2002;10(19):978–983
7. Mai WX, Meng H. Mesoporous silica nanoparticles: a multifunctional nano therapeutic system. Integr Biol (Camb). 2013;5(1):19–28
8. Trewyn BG, Giri S, Slowing II, Lin VS. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun (Camb). 2007(31):3236–3245
9. Wang K, He X, Yang X, Shi H. Functionalized silica nanoparticles: a platform for fluorescence imaging at the cell and small animal levels. Acc Chem Res. 2013;46(7):1367–1376
10. Park YH, Bae H, Jang Y, et al. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol Cell Toxicol. 2013;9(1):67–74
11. Musa M, Kannan T, Masudi SA, Rahman I. Assessment of DNA damage caused by locally produced hydroxyapatite-silica nanocomposite using Comet assay on human lung fibroblast cell line. Mol Cell Toxicol. 2012;8(1):53–60
12. Ahamed M. Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells. Hum Exp Toxicol. 2013;32(2):186–195
13. Lai JC, Ananthakrishnan G, Jandhyam S, et al. Treatment of human astrocytoma U87 cells with silicon dioxide nanoparticles lowers their survival and alters their expression of mitochondrial and cell signaling proteins. Int J Nanomedicine. 2010;5:715–723
14. Duan J, Yu Y, Li Y, Sun Z. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials. 2013;34(23):5853–5862
15. Park EJ, Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett. 2009;184(1):18–25
16. Yu Y, Li Y, Wang W, et al. Acute toxicity of amorphous silica nanoparticles in intravenously exposed ICR mice. PLoS One. 2013;8(4): e61346
17. Xie G, Sun J, Zhong G, Shi L, Zhang D. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch Toxicol. 2010;84(3):183–190
18. Liu T, Li L, Teng X, et al. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials. 2011;32(6):1657–1668
19. 2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol In Vitro. 2010;24(3):751–758
20. 2 nanoparticles on HFL-I activating ROS-mediated apoptosis via p53 pathway. J Appl Toxicol. 2012;32(5):358–364
21. Passagne I, Morille M, Rousset M, Pujalte I, L’Azou B. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. Toxicology. 2012;299(2–3):112–124
22. Ye Y, Liu J, Chen M, Sun L, Lan M. In vitro toxicity of silica nanoparticles in myocardial cells. Environ Toxicol Pharmacol. 2010;29(2): 131–137
23. Rim K, Kim S, Song S, Park J. Effect of cerium oxide nanoparticles to inflammation and oxidative DNA damages in H9c2 cells. Mol Cell Toxicol. 2012;8(3):271–280
24. Lee B, Kim K, Cho J, et al. Oxidative stress in juvenile common carp (Cyprinus carpio) exposed to TiO2 nanoparticles. Mol Cell Toxicol. 2012;8(4):357–366
25. Ivanov S, Zhuravsky S, Yukina G, Tomson V, Korolev D, Galagudza M. In vivo toxicity of intravenously administered silica and silicon nanoparticles. Materials. 2012;5(10):1873–1889
26. Shrivastava S, McCallum SA, Nuffer JH, Qian X, Siegel RW, Dordick JS. Identifying specific protein residues that guide surface interactions and orientation on silica nanoparticles. Langmuir. 2013;29(34):10841–10849
27. Vertegel AA, Siegel RW, Dordick JS. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir. 2004;20(16):6800–6807
28. Kim KM, Kim HM, Choi MH, et al. Colloidal properties of surface coated colloidal silica nanoparticles in aqueous and physiological solutions. Sci Adv Mat. 2014;6(7):1573–1581
29. Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093
30. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008;105(38):14265–14270
31. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology. 2009;20(45):455101
32. Fleischer CC, Payne CK. Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B. 2012;116(30):8901–8907
33. Zhang H, Burnum KE, Luna ML, et al. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size. Proteomics. 2011;11(23):4569–4577
34. Darabi Sahneh F, Scoglio C, Riviere J. Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations. PLoS One. 2013;8(5):e64690
35. Cedervall T, Lynch I, Lindman S, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Sci Acad U S A. 2007;104(7): 2050–2055
36. Cedervall T, Lynch I, Foy M, et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl. 2007;46(30):5754–5756
37. Cushley RJ, Okon M. NMR studies of lipoprotein structure. Annu Rev Biophys Biomol Struct. 2002;31:177–206
38. Kreuter J, Shamenkov D, Petrov V, et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target. 2002;10(4):317–325
39. Wu J, Wang C, Sun J, Xue Y. Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano. 2011;5(6):4476–4489
40. Nabeshi H, Yoshikawa T, Matsuyama K, et al. Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application. Biomaterials. 2011;32(11):2713–2724
41. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol. 2011;6(1):39–44
42. Salvador-Morales C, Flahaut E, Sim E, Sloan J, Green ML, Sim RB. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol. 2006;43(3):193–201
43. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2007;2(8):469–478
44. Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 2008;8(8):2180–2187
45. Johnson-Lyles DN, Peifley K, Lockett S, et al. Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2010;248(3):249–258
46. Nel AE, Madler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8(7):543–557.